{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreif2oehkrm3hr6uqqdurrabf7d2ylo7ijo6j3dlfllotsrt4pixyfy",
    "uri": "at://did:plc:4kwqvtwyj7nywt3v7ra2cuy4/app.bsky.feed.post/3mfol3hk3gp62"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreiaotrbtp6zxucjgqsgbfm3ibgxoej55xewpockjgriw2c64qgqpem"
    },
    "mimeType": "image/jpeg",
    "size": 209310
  },
  "path": "/content/b2b4743a-3723-44d0-8573-b6eac2f4b10b",
  "publishedAt": "2026-02-25T09:26:52.000Z",
  "site": "https://www.ft.com",
  "textContent": "New chief Luke Miels swoops on Canada’s 35Pharma in push to replenish pipeline and boost revenues",
  "title": "GSK secures potential ‘multi-blockbuster’ drug in $950mn deal"
}